Rochwerg, Bram
Einav, Sharon
Chaudhuri, Dipayan http://orcid.org/0000-0002-8305-1481
Mancebo, Jordi
Mauri, Tommaso
Helviz, Yigal
Goligher, Ewan C.
Jaber, Samir
Ricard, Jean-Damien
Rittayamai, Nuttapol
Roca, Oriol
Antonelli, Massimo
Maggiore, Salvatore Maurizio
Demoule, Alexandre
Hodgson, Carol L.
Mercat, Alain
Wilcox, M. Elizabeth
Granton, David
Wang, Dominic
Azoulay, Elie
Ouanes-Besbes, Lamia
Cinnella, Gilda
Rauseo, Michela
Carvalho, Carlos
Dessap-Mekontso, Armand
Fraser, John
Frat, Jean-Pierre
Gomersall, Charles
Grasselli, Giacomo
Hernandez, Gonzalo
Jog, Sameer
Pesenti, Antonio
Riviello, Elisabeth D.
Slutsky, Arthur S.
Stapleton, Renee D.
Talmor, Daniel
Thille, Arnaud W.
Brochard, Laurent
Burns, Karen E. A.
Funding for this research was provided by:
European Society of Intensive Care Medicine
Article History
Received: 22 September 2020
Accepted: 22 October 2020
First Online: 17 November 2020
Compliance with ethical standards
:
: SE received funding for travel, given lectures, owns patents with and/or performed consultancy work for Zoll, Medtronic and Diasorin and has participated in multicentre trials run by Artisanpharma, Eisai and Astra Zeneca. JM received personal fees from Faron Pharmaceuticals, Medtronic and Janssen; IMT Medical provided travel and hotel expenses to attend a meeting; he is a coinvestigator on a PAV + multinational trial funded by the CIHR in partnership with Covidien (Medtronic); more than 3 years ago Fisher-Paykel, General Electric and A-Lung provided grant funding to conduct clinical research. TM received lecture fees from Drager, Fisher and Paykel, Mindray and BBraun. EG supported by an Early Career Investigator award from the Canadian Institutes of Health Research. He receives financial and nonfinancial support from Getinge and Timpel outside the submitted work. SJ received Consulting fees from Drager, Xenios, and Fisher & Paykel. J-DR received travel expenses and accommodation coverage from Fisher&Paykel Healthcare to attend scientific meetings. Fisher&Paykel Healthcare provided support for the ongoing High Flow ACRF trial (NCT03406572) but took no part in design or conduct of the study. NR received travel expenses and lecture fees from Fisher&Paykel. OR’s institution received fees for consultation from Hamilton Medical and received lecture fees from Air Liquide. MA’s institution received unrestricted research grant from Fisher & Paykel and GE Healthcare, he received consulting fees from Getinge and Intersurgical. SMM received consulting fees from Draeger Medical and General Electric Healthcare; his Institution received a research grant from Fisher and Paykel Healthcare (the RINO trial, <u>clinicaltrials.gov</u> NCT02107183). AD reports research grants from Philips, Respinor, Lungpacer, French Ministry of Health, Fisher and Paykel Healthcare (the RINO trial, <u>clinicaltrials.gov</u> NCT02107183), financial and nonfinancial support from Fisher&Paykel (including payment for lectures and registration to one scientific meeting), personal fees from Baxter (board meeting), Hamilton (lecture), Getinge (lecture), Lowenstein (advisory board). CH was supported by a Heart Foundation Fellowship. AM received personal fees from Faron Pharmaceuticals, Air Liquid Medical Systems, Pfizer, Resmed and Draeger and grants and personal fees from Fisher and Paykel and Covidien. EA has received fees for lectures from Gilead, Pfizer, Baxter, and Alexion. His research group has been supported by Ablynx, Fisher & Paykel, Jazz Pharma, and MSD. GC received consulting fees from Maquet. AD-M reports research grants from Fisher Paykel, Baxter, Philips, Ferring and GSK; participation to advisory board for Air Liquide, Baxter, and Amomed, lectures for Getinge and Addmedica. JF received grant funding and travel support to meetings from Fisher Paykel ( no role in research from FP) and Xenios. His research group has received research support from CSL, Timpel, Draeger. J-PF received travel expenses and lectures fees from Fisher&Paykel and SOS oxygene. GG received travel expenses and lecture fees from Getinge, Draeger Medical, MSD, Fisher&Paykel, Thermofisher and Biotest. GH received personal fees and travel expenses from Fisher and Paykel Healthcare. AT received financial and nonfinancial support from Fisher&Paykel (including payment for lectures and travel expense coverage to attend scientific meetings), and received financial support from Covidien, Maquet-Getinge, and GE Healthcare outside the submitted work. LB conducts an investigator-initiated trial on PAV + funded by the Canadian Institute for Health Research in partnership with Medtronic Covidien. His laboratory also received grants and non-financial support from Fisher & Paykel, non-financial support from Air Liquide, non-financial support from Philips, non-financial support from Sentec, other from General Electric.
Free to read: This content has been made available to all.